Maxim Group Starts Neurobo Pharmaceuticals (NRBO) at Buy, 'Right Spaces at the Right Time; Targeting Obesity and MASH'
Tweet Send to a Friend
(Updated - May 8, 2024 8:41 AM EDT)
Maxim Group analyst Jason McCarthy initiates coverage on Neurobo Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Maxim Group analyst Jason McCarthy initiates coverage on Neurobo Pharmaceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
